Skyrizi 150 mg

SKYRIZI 150 MG is a subcutaneous solution containing risankizumab, used for managing moderate to severe plaque psoriasis. This biologic medication helps reduce inflammation and improve skin condition.

SKYRIZI 150 MG is primarily used for the treatment of moderate to severe plaque psoriasis in adults. This medication works by targeting specific proteins in the body to reduce inflammation and slow down the overproduction of skin cells. People often ask, 'What is SKYRIZI used for?' and the answer is that it is designed to help manage symptoms of psoriasis, including red, itchy, and scaly patches on the skin.

Common effects of SKYRIZI 150 MG may include reactions at the injection site, such as redness, itching, or pain. Some individuals might experience upper respiratory infections, headache, or fatigue. These effects vary and are not experienced by everyone.

SKYRIZI 150 MG should be handled with care. It is important to follow the instructions provided by your healthcare professional. Store the medication as directed, typically in a refrigerator, and protect it from light. Always check the solution for particles or discoloration before use.

SKYRIZI 150 MG may interact with other medications, including biologics or drugs that affect the immune system. It is important to inform your healthcare provider about all medications you are taking. Alcohol and certain supplements might also interact with this medication.